UK pharmaceutical giant AstraZeneca PLC on Friday said that it was abandoning plans to build a ￡450 million (US$557.5 million) vaccine plant, a major blow to the Labour Party government’s plans to revive a sluggish economy.
“Following protracted discussions with the government, we are no longer pursuing our planned investment” for Speke in Liverpool, northwest England, a company spokesperson said.
The company cited “timing” issues and a “reduction” in the public subsidies offered by the Labour government compared with its Conservative predecessor.
Photo: REUTERS
A source close to the issue said that British Prime Minister Keir Starmer’s government, elected in July last year, was proposing ￡40 million in subsidies compared with the ￡90 million offered previously.
A government spokesperson said that “a change in the make-up of the investment originally proposed by AstraZeneca led to a reduced government grant offer being put forward.”
“All government grant funding has to demonstrate value for the taxpayer and unfortunately, despite extensive work from government officials, it has not been possible to achieve a solution,” the spokesperson added.
The group already has a factory on the site, which would not be affected by the decision and would continue to produce flu vaccines.
The UK government did not immediately respond when asked for comment.
However, media reports called it a snub to British Chancellor of the Exchequer Rachel Reeves, who has tried in recent weeks to reassure companies worried about tax rises on employers announced at the end of October last year.
Reeves, who has said for months that growth is her priority, on Wednesday outlined a recovery plan whose flagship measure was the government’s approval of a third runway at Heathrow, the largest airport in the UK and Europe.
She also announced relaxations of planning rules and deregulation measures to boost investment, as well as backing several investment projects to make the Oxford-Cambridge axis a “European Silicon Valley.”
Having already stalled in the third quarter and then fallen in October, the UK’s GDP rebounded by a less-than-expected 0.1 percent in November last year. However, the IMF mid last month revised upward its growth forecast for the country this year to 1.6 percent.
The Society of Chemical Industry called AstraZeneca’s decision a “real concern for industry,” because it sent “out the wrong message at a time government is shaping its new industrial strategy.”
“If life sciences are going to be a major pillar of the UK’s new industrial strategy, then the UK needs to make some bold steps forward to ensure it is competitive for life sciences investments,” said the society’s chief executive, Sharon Todd.
To many, Tatu City on the outskirts of Nairobi looks like a success. The first city entirely built by a private company to be operational in east Africa, with about 25,000 people living and working there, it accounts for about two-thirds of all foreign investment in Kenya. Its low-tax status has attracted more than 100 businesses including Heineken, coffee brand Dormans, and the biggest call-center and cold-chain transport firms in the region. However, to some local politicians, Tatu City has looked more like a target for extortion. A parade of governors have demanded land worth millions of dollars in exchange
An Indonesian animated movie is smashing regional box office records and could be set for wider success as it prepares to open beyond the Southeast Asian archipelago’s silver screens. Jumbo — a film based on the adventures of main character, Don, a large orphaned Indonesian boy facing bullying at school — last month became the highest-grossing Southeast Asian animated film, raking in more than US$8 million. Released at the end of March to coincide with the Eid holidays after the Islamic fasting month of Ramadan, the movie has hit 8 million ticket sales, the third-highest in Indonesian cinema history, Film
Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) revenue jumped 48 percent last month, underscoring how electronics firms scrambled to acquire essential components before global tariffs took effect. The main chipmaker for Apple Inc and Nvidia Corp reported monthly sales of NT$349.6 billion (US$11.6 billion). That compares with the average analysts’ estimate for a 38 percent rise in second-quarter revenue. US President Donald Trump’s trade war is prompting economists to retool GDP forecasts worldwide, casting doubt over the outlook for everything from iPhone demand to computing and datacenter construction. However, TSMC — a barometer for global tech spending given its central role in the
Alchip Technologies Ltd (世芯), an application-specific integrated circuit (ASIC) designer specializing in server chips, expects revenue to decline this year due to sagging demand for 5-nanometer artificial intelligence (AI) chips from a North America-based major customer, a company executive said yesterday. That would be the first contraction in revenue for Alchip as it has been enjoying strong revenue growth over the past few years, benefiting from cloud-service providers’ moves to reduce dependence on Nvidia Corp’s expensive AI chips by building their own AI accelerator by outsourcing chip design. The 5-nanometer chip was supposed to be a new growth engine as the lifecycle
RSS